Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 46 AL 60

Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer's disease (AD) mimickers

Sofia L, Massa F, Raffa S, Pardini M, Arnaldi D, Bauckneht M, Morbelli S.

Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2843-2845. doi: 10.1007/s00259-024-06676-z. Epub 2024 Mar 14.

[An arachnoid cyst mimicking a symptomatic Alzheimer's disease]

Beltrani S, Funk J, Lieb J, Ehrensperger MM, Sollberger M.

Nervenarzt. 2024 Jun;95(6):560-563. doi: 10.1007/s00115-024-01638-0. Epub 2024 Mar 14.

Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study

Cesana BM, Bergh S, Ciccone A, Cognat E, Fabbo A, Fascendini S, Frisoni GB, Froelich L, Handels R, Jori MC, Mecocci P, Merlo P, Peters O, Tsolaki M, Defanti CA.

J Alzheimers Dis. 2024;98(3):1043-1052. doi: 10.3233/JAD-230878.

Linking Type and Extent of Head Trauma to Cavum Septum Pellucidum in Older Adults With and Without Alzheimer Disease and Related Dementias

Asken BM, Tanner JA, Vandevrede L, Apple A, Chapleau M, Gaynor LS, Lane-Donovan C, Lenio S, Yadollahikhales G, Lee S, Gontrum E, Knudtson M, Iaccarino L, La Joie R, Cobigo Y, Staffaroni AM, Casaletto KB, Gardner RC, Grinberg LT, Gorno-Tempini ML, Rosen HJ, Seeley WW, Miller BL, Kramer J, Rabinovici GD.

Neurology. 2024 Apr 9;102(7):e209183. doi: 10.1212/WNL.0000000000209183. Epub 2024 Mar 15.

Case report: Rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia

Miskovic R, Ljubicic J, Bonaci-Nikolic B, Petkovic A, Markovic V, Rankovic I, Djordjevic J, Stankovic A, Klaassen K, Pavlovic S, Stojanovic M.

Front Immunol. 2024 Mar 4;15:1324679. doi: 10.3389/fimmu.2024.1324679. eCollection 2024.

Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease

Zhou C, Zeng F, Yang H, Liang Z, Xu G, Li X, Liu X, Yang J.

Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):2953-2969. doi: 10.1007/s00259-024-06690-1. Epub 2024 Mar 19.

The role of 123-I-MIBG cardiac scintigraphy in the differential diagnosis between dementia with Lewy bodies and Alzheimer's disease

Monzio Compagnoni G, Appollonio I, Ferrarese C.

Neurol Sci. 2024 Aug;45(8):3599-3609. doi: 10.1007/s10072-024-07476-x. Epub 2024 Mar 22.

Effects of Aerobic Exercise on Executive and Memory Functions in Patients With Alzheimer's Disease: A Systematic Review

Luo Q, Tian Z, Hu Y, Wang C.

J Aging Phys Act. 2024 Mar 23;32(4):541-553. doi: 10.1123/japa.2023-0292. Print 2024 Aug 1.

Lower Accuracy Alzheimer Disease Blood Tests Will Never Be "Ready for Prime Time"

Buckley RF, Schindler SE.

Neurology. 2024 Apr 23;102(8):e209295. doi: 10.1212/WNL.0000000000209295. Epub 2024 Mar 25.

Randomized controlled trial of a positive emotion regulation intervention to reduce stress in family caregivers of individuals with Alzheimer's disease: protocol and design for the LEAF 2.0 study

Leong CA, Summers A, Grote V, Jackson K, Dowling G, Snowberg K, Cotten P, Cheung E, Yang D, Addington EL, Moskowitz JT.

BMC Geriatr. 2024 Mar 27;24(1):289. doi: 10.1186/s12877-024-04817-5.

Neuromodulation by nanozymes and ultrasound during Alzheimer's disease management

Karthika V, Badrinathan Sridharan, Nam JW, Kim D, Gyun Lim H.

J Nanobiotechnology. 2024 Mar 30;22(1):139. doi: 10.1186/s12951-024-02406-7.

Socially Assistive Robots for patients with Alzheimer's Disease: A scoping review

Karami V, Yaffe MJ, Gore G, Moon A, Abbasgholizadeh Rahimi S.

Arch Gerontol Geriatr. 2024 Aug;123:105409. doi: 10.1016/j.archger.2024.105409. Epub 2024 Mar 12.

Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective

Shukla D, Suryavanshi A, Bharti SK, Asati V, Mahapatra DK.

Curr Top Med Chem. 2024;24(19):1699-1737. doi: 10.2174/0115680266299847240328045737.

Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab

Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, Curiale GG, Tian Y, Patel D, von Rosenstiel P, von Hehn C, Salloway S, Hock C, Nitsch RM, Haeberlein SB, Sandrock A, Singhal P.

Alzheimers Dement. 2024 May;20(5):3406-3415. doi: 10.1002/alz.13755. Epub 2024 Apr 3.

Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol

Svensson JE, Bolin M, Thor D, Williams PA, Brautaset R, Carlsson M, Sörensson P, Marlevi D, Spin-Neto R, Probst M, Hagman G, Morén AF, Kivipelto M, Plavén-Sigray P.

BMC Neurol. 2024 Apr 4;24(1):111. doi: 10.1186/s12883-024-03596-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias